id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-342231-862kffnb	Carneiro, Thiago	Intravenous tPA for Acute Ischemic Stroke in Patients with COVID-19	2020-07-27		.txt	text/plain	1857	128	51	Background/Purpose: Coronavirus disease 2019 (COVID-19) is associated with increased risk of acute ischemic stroke (AIS), however, there is a paucity of data regarding outcomes after administration of intravenous tissue plasminogen activator (IV tPA) for stroke in patients with COVID-19. Background/Purpose: Coronavirus disease 2019 (COVID-19) is associated with increased risk of acute ischemic stroke (AIS), however, there is a paucity of data regarding outcomes after administration of intravenous tissue plasminogen activator (IV tPA) for stroke in patients with COVID-19. 1 We present the outcomes of a multicenter series of patients with confirmed COVID-19 infection who were treated with IV tPA for suspected acute ischemic stroke. All patients included were diagnosed with COVID-19 by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RT-PCR from a nasopharyngeal swab, presented with acute neurological deficits (< 24 hours), received IV tPA per acute ischemic stroke American Heart Association guidelines, and underwent brain and intracranial vessel imaging.	./cache/cord-342231-862kffnb.txt	./txt/cord-342231-862kffnb.txt